Full-Time

Senior Logistics Compliance Analyst

Intuitive Surgical

Intuitive Surgical

10,001+ employees

Manufactures robotic surgical systems and services

No salary listed

Norcross, GA, USA

Hybrid

Three days on-site per week required.

Bachelor's

Category
Operations & Logistics (1)
Required Skills
SAP Products
Word/Pages/Docs
Risk Management
Data Governance
Excel/Numbers/Sheets

Get referred to Intuitive Surgical

See people who can refer or advise you

Requirements
  • Expert knowledge of customs regulations, FDA importing regulations, EAR & Census Trade requirements.
  • Strong knowledge of Customs regulations, import and export classification, free trade agreement and training skills.
  • Strong analytical skills, critical thinking, and problem solving with experience in risk management processes and gap analysis.
  • Proficient at multi-tasking, well organized and reliable for consistent decision making and follow through.
  • Work effectively both independently and collaboratively.
  • Demonstrated ability to deliver creative and practical solutions to solve complex logistics and impact of current and potential regulatory compliance issues.
  • Ability to manage and drive change.
  • Experience in Supply Chain Security Program and duty drawback.
  • Excellent oral and written communication, facilitation, and collaboration.
  • Excellent in research and analytical skills.
  • Detail oriented and highly organized with ability to multi-task and minimal guidance.
  • Proficient in the use of Microsoft Outlook, Word, Excel, and PowerPoint.
  • Strong ability to create innovative solutions from existing resources.
  • Ability to evaluate data and issues.
  • Excellent time management skills.
  • Ability to interpret regulatory requirements and implement appropriately.
  • Must be a team player, amenable to a variety of work projects.
  • Strong cross-functional collaboration skills and ability to influence others through demonstrated expertise. Ability to manage multiple cross- organizational projects.
  • Interpersonal skills to deal effectively with all levels of the organization.
  • Travel up to 10%.
  • Bachelor’s degree in supply chain, international business, finance or similar.
  • 7+ years of experience in Trade Compliance / Logistics Operations Compliance in medical devices.
  • Licensed Customs Broker – U.S. or similar professional trade certifications.
Responsibilities
  • Perform import/export activities in compliance with government rules and regulations, organizational policies, procedures, goals, and objectives.
  • Manage issues related to proper legal interpretation and determination of the Harmonized Tariff Schedule, Country of Origin, Customs Valuations, ECCN, International Trade Administration’s anti-dumping regulated product flows, duty drawback, duty suspension, and other governmental programs driving exemptions of products and purchases.
  • Manage compliance with preferential-and non-preferential trade programs and issue certificates as applicable.
  • Responsible for the Customs reconciliation and anti-boycott programs.
  • Audit and maintain data governance in SAP/ product database and applicable trade compliance records in accordance with regulatory requirements.
  • Create and maintain import/ export compliance manuals, policies and procedures, SOPs, and trade compliance guidelines.
  • Assist Logistics Compliance manager in researching Customs- and regulatory requirements for new destination markets including classification, import licenses, valuation, documentation, and import- and export restrictions and communicate back to medical device business.
  • Interact with IT and Center of Excellence (COE) to streamline and improve import/ export data for compliance; communicate requirements to IT and assist with testing and solutions implementation.
  • Miscellaneous Tariff Bill – monitor, determination of products and filing of new petitions.
  • Monitor and alert new trade policies globally – such as Section 301.
  • Maintains adherence to and assist with the Customs-Trade Partnership Against Terrorism (C-TPAT) implementation and annual validation.
  • Submit and monitor import/ export permit/ license applications as needed.
  • Conduct and report findings of internal risk assessments. Follow-up with Compliance Improvement Plans.
  • Provide training to other functional groups on import and export requirements.
  • Assist in global and/or regional compliance projects/programs.
  • Develop and generate compliance and service provider performance reports for management.
  • Assist in development and maintenance of operational processes and procedures to improve workflows and process.
  • Assist in defining Intuitive audit guidelines to monitor customer/ order compliance and aid in determining future training/ procedural needs.
  • Communicate company policies and procedures to internal and external stakeholders.
  • Provide assistance to company sites, suppliers, and customers in the continuous improvement of their compliance functions.
  • Perform other duties, tasks, special projects as assigned.
Desired Qualifications
  • Experience in implementing and maintaining Global Trade Management Software.
  • Experience in SAP S4/ HANA and related transactional and outputs are preferred.
  • Previous customs compliance experience is preferred.

Intuitive Surgical designs, manufactures, and sells robotic surgical systems and provides related services and accessories for minimally invasive surgery. The core product helps surgeons perform operations with enhanced precision by guiding robotic arms controlled from a console, allowing procedures to be done through small incisions. Instruments and consumables are used with the systems and are supported by service contracts, creating a recurring revenue stream. Compared to competitors, Intuitive has a large installed base and focuses specifically on robotic-assisted surgery, combining devices, disposable instruments, and ongoing services to support hospitals and surgical centers. Its goal is to improve patient outcomes by enabling safer, less invasive procedures while expanding the use and capabilities of robotic surgery for more procedures and providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Get referred to Intuitive Surgical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue reached $2.89 billion, up 19%, with 70% gross margin.
  • Europe direct operations started March 2, 2026, adding Italy, Spain, Portugal, and Malta.
  • Ion procedures grew 36% in Q2 2026, expanding beyond da Vinci dependence.

What critics are saying

  • FDA posted a Class II da Vinci 5 recall on February 18, 2026.
  • Surgical Instrument Service and the FTC pressed Ninth Circuit antitrust claims on June 25, 2026.
  • US da Vinci growth slowed to 12% in Q2 2026, threatening premium pricing.

What makes Intuitive Surgical unique

  • Da Vinci 5 cleared for cardiac procedures on January 26, 2026.
  • Intuitive owns 11,710 da Vinci and 1,096 Ion systems, creating switching costs.
  • July 23, 2026 AI platform leverages 20 million procedures, unmatched surgical data scale.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Aug 8th, 2026
Medtronic and Intuitive Surgical lag market amid sector weakness

Medtronic and Intuitive Surgical, two medical device leaders, have underperformed this year due to sector weakness and company-specific challenges. However, both show potential for recovery. Medtronic's fourth-quarter revenue rose 9.9% to $9.8 billion, though adjusted earnings per share fell 4.3% to $1.55 due to higher costs, including tariffs. The company posted its highest annual revenue growth in a decade, driven partly by its Pulse Field Ablation franchise. Medtronic recently received FDA clearance for its Hugo robotic-assisted surgery system for urologic procedures, positioning it to compete in the underpenetrated robotic surgery market. The company plans to spin off its lower-margin diabetes care division, which should improve margins. With a 3.4% forward dividend yield and 49 consecutive years of payout increases, Medtronic appeals to income-focused investors.

Yahoo Finance
Jul 29th, 2026
Intuitive Surgical stock falls 27% despite 31% operating margin and strong da Vinci system sales

Intuitive Surgical's stock has fallen 27% over the past twelve months, now trading 41% below its two-year high. The robotic surgery pioneer trades at 40.8 times earnings, the highest valuation in its sector. The company maintains a 31% operating margin, outpacing Johnson & Johnson's 27% and Medtronic's 18.8%. Revenue grew 21% over the last twelve months. The firm placed 468 da Vinci systems in the most recent quarter, an 18% increase year-over-year, driven by demand for its new da Vinci 5 platform. However, US procedure growth slowed to 12%, compared to 15% worldwide growth. Management attributed the slowdown to changes in patient coverage and premium dynamics causing treatment deferrals.

Yahoo Finance
Jul 20th, 2026
Intuitive Surgical shares drop 14% despite $2.89B revenue as US procedure growth slows to 12%

Intuitive Surgical reported second-quarter revenue of $2.89 billion, up 19% year-on-year and beating Wall Street estimates. Despite this, shares fell 14.1% to a new 52-week low on Friday. The drop followed concerns about slowing US procedure volumes. Whilst global procedures grew 16%, growth for da Vinci systems in the critical US market moderated to 12%. Management noted that changes in patient coverage may be affecting demand for elective procedures. Paradoxically, capital equipment sales remained strong, with 468 da Vinci systems placed in the quarter, up 18% year-on-year. US placements jumped 24%, driven by the new da Vinci 5 platform. Management also detailed plans for an extended use programme launching in 2027, aimed at reducing costs but potentially impacting high-margin recurring revenue.

Yahoo Finance
Jul 16th, 2026
Intuitive Surgical Q2 revenue climbs 19% to $2.89B as procedures grow 16% globally

Intuitive Surgical reported strong Q2 results, with revenue up 19% year-over-year to $2.89 billion and non-GAAP earnings per share rising 28% to $2.80. Recurring revenue accounted for 85% of total sales. Total procedures increased 16%, driven by 15% growth in da Vinci procedures and 36% growth in Ion procedures. Whilst US growth slowed, international da Vinci procedures rose 20%, expanding across Europe and Asia. The company maintained its 2026 procedure outlook, keeping da Vinci procedure growth guidance at 13.5% to 15.5% whilst raising its non-GAAP gross margin forecast to 68% to 69%. Management highlighted continued demand for newer platforms including da Vinci 5, SP and Ion. The installed base grew to nearly 13,000 systems worldwide.

Yahoo Finance
Jul 16th, 2026
Intuitive Surgical beats Q2 revenue estimates with $2.89B but shares fall on surgery volume concerns

Intuitive Surgical reported second-quarter revenue of $2.89 billion, up 18.5% year on year and beating Wall Street estimates of $2.82 billion. The medical technology company's non-GAAP profit of $2.80 per share exceeded analyst expectations by 11.9%. Despite the strong results, the stock declined. The drop was attributed to recent declines in overall surgery volumes reported by major healthcare providers and a Class II recall of certain da Vinci surgical components. Operating margin improved to 33.6%, up from 30.5% in the same quarter last year. Analysts expect revenue to grow 12.5% over the next 12 months, representing a deceleration from recent growth rates. The company has demonstrated solid long-term performance, with 16.4% annualised revenue growth over the past five years.